Bioabsorbable stents sales will grow through 2036, led by coronary artery stents at 68% of the stents segment in 2026, driven by clinical demand and treatment protocol requirements. The market was valued at USD 185.8 million in 2025 and is expected to be worth USD 286.0 million by 2036.